Elevated SNHG3 levels were significantly associated with poor OS in bladder cancer [6], clear cell renal cell carcinoma [12, 13], colorectal carcinoma [14, 15], gastric cancer [18, 25, 49], osteosarcoma [26], and ovarian cancer [19, 28, 29, 32]. This evidence concerns the gene SNHG3 and clear cell renal carcinoma.